What's in Guangzhou Double Bioproducts Co., Ltd's pipeline?

Guangzhou Double Bioproducts Co., Ltd has 3 drugs in our index: 1 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Guangzhou Double Bioproducts Co., Ltd's portfolio?

Top competitors by shared drug class: Akeso, Sun Yat-sen University, Merck Sharp & Dohme LLC, Aravive, Inc., BeyondSpring Pharmaceuticals Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/guangzhou-double-bioproducts-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Guangzhou Double Bioproducts Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Guangzhou Double Bioproducts Co., Ltd pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Paclitaxel injection	Paclitaxel injection	marketed	Taxane; microtubule stabilizer	β-tubulin	Oncology
Cisplatin injection	Cisplatin injection	phase 3	Platinum-based chemotherapy agent	DNA	Oncology
Endostatins	Endostatins	phase 3			Other

Therapeutic area mix

Oncology · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Akeso · 2 shared drug classes
Sun Yat-sen University · 2 shared drug classes
Merck Sharp & Dohme LLC · 2 shared drug classes
Aravive, Inc. · 1 shared drug class
BeyondSpring Pharmaceuticals Inc. · 1 shared drug class
Bio-Thera Solutions · 1 shared drug class
Barts & The London NHS Trust · 1 shared drug class
Biocad · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Guangzhou Double Bioproducts Co., Ltd:

Cite this brief

Drug Landscape (2026). Guangzhou Double Bioproducts Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/guangzhou-double-bioproducts-co-ltd. Accessed 2026-05-17.